世界の自己免疫疾患治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Autoimmune Disease Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5604
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、自己免疫疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（NSAID、抗炎症、インターフェロン、抗高血糖、その他）、用途別市場規模（関節リウマチ、1型糖尿病、多発性硬化症、乾癬、狼瘡、炎症性腸疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・自己免疫疾患治療薬の市場動向
・企業の競争状況、市場シェア
・自己免疫疾患治療薬の種類別市場規模と予測2016-2027（NSAID、抗炎症、インターフェロン、抗高血糖、その他）
・自己免疫疾患治療薬の用途別市場規模と予測2016-2027（関節リウマチ、1型糖尿病、多発性硬化症、乾癬、狼瘡、炎症性腸疾患、その他）
・自己免疫疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・自己免疫疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・自己免疫疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・自己免疫疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・自己免疫疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Abbott Laboratories、Pfizer、AbbVie、Eli Lilly、Bristol-Myers Squibb、AstraZeneca plc、GlaxoSmithKline、Roche、Biogen、Amgen）
・結論

Autoimmune disease is a condition in which the immune system is unable to recognize the body’s own cells and starts attacking them. The immune system might attack different types of body cells, depending on which the autoimmune disease is classified. This disease might result in degradation as well as improper functioning of body organs.

Market Analysis and Insights: Global Autoimmune Disease Drug Market
The global Autoimmune Disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Drug market.

Global Autoimmune Disease Drug Scope and Market Size
Autoimmune Disease Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others

Segment by Application
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Pfizer
AbbVie
Eli Lilly
Bristol-Myers Squibb
AstraZeneca plc
GlaxoSmithKline
Roche
Biogen
Amgen

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 NSAIDs
1.2.3 Anti-Inflammatory
1.2.4 Interferons
1.2.5 Antihyperglycemics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Type 1 Diabetes
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Lupus
1.3.7 Inflammatory Bowel Disease
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Autoimmune Disease Drug Market Perspective (2016-2027)
2.2 Autoimmune Disease Drug Growth Trends by Regions
2.2.1 Autoimmune Disease Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disease Drug Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disease Drug Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disease Drug Industry Dynamic
2.3.1 Autoimmune Disease Drug Market Trends
2.3.2 Autoimmune Disease Drug Market Drivers
2.3.3 Autoimmune Disease Drug Market Challenges
2.3.4 Autoimmune Disease Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Drug Players by Revenue
3.1.1 Global Top Autoimmune Disease Drug Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disease Drug Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Drug Revenue
3.4 Global Autoimmune Disease Drug Market Concentration Ratio
3.4.1 Global Autoimmune Disease Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Drug Revenue in 2020
3.5 Autoimmune Disease Drug Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Drug Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Autoimmune Disease Drug Breakdown Data by Type
4.1 Global Autoimmune Disease Drug Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disease Drug Forecasted Market Size by Type (2022-2027)

5 Autoimmune Disease Drug Breakdown Data by Application
5.1 Global Autoimmune Disease Drug Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disease Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Autoimmune Disease Drug Market Size (2016-2027)
6.2 North America Autoimmune Disease Drug Market Size by Type
6.2.1 North America Autoimmune Disease Drug Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disease Drug Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disease Drug Market Size by Type (2016-2027)
6.3 North America Autoimmune Disease Drug Market Size by Application
6.3.1 North America Autoimmune Disease Drug Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disease Drug Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disease Drug Market Size by Application (2016-2027)
6.4 North America Autoimmune Disease Drug Market Size by Country
6.4.1 North America Autoimmune Disease Drug Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disease Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Autoimmune Disease Drug Market Size (2016-2027)
7.2 Europe Autoimmune Disease Drug Market Size by Type
7.2.1 Europe Autoimmune Disease Drug Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disease Drug Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disease Drug Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disease Drug Market Size by Application
7.3.1 Europe Autoimmune Disease Drug Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disease Drug Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disease Drug Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disease Drug Market Size by Country
7.4.1 Europe Autoimmune Disease Drug Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disease Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Drug Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disease Drug Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disease Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disease Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disease Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disease Drug Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disease Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disease Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disease Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disease Drug Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disease Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Autoimmune Disease Drug Market Size (2016-2027)
9.2 Latin America Autoimmune Disease Drug Market Size by Type
9.2.1 Latin America Autoimmune Disease Drug Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disease Drug Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disease Drug Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disease Drug Market Size by Application
9.3.1 Latin America Autoimmune Disease Drug Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disease Drug Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disease Drug Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disease Drug Market Size by Country
9.4.1 Latin America Autoimmune Disease Drug Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disease Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Drug Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disease Drug Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disease Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disease Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disease Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disease Drug Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disease Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disease Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disease Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disease Drug Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disease Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Drug Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Autoimmune Disease Drug Introduction
11.2.4 Pfizer Revenue in Autoimmune Disease Drug Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Autoimmune Disease Drug Introduction
11.3.4 AbbVie Revenue in Autoimmune Disease Drug Business (2016-2021)
11.3.5 AbbVie Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Autoimmune Disease Drug Introduction
11.4.4 Eli Lilly Revenue in Autoimmune Disease Drug Business (2016-2021)
11.4.5 Eli Lilly Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Autoimmune Disease Drug Introduction
11.5.4 Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2016-2021)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 AstraZeneca plc
11.6.1 AstraZeneca plc Company Details
11.6.2 AstraZeneca plc Business Overview
11.6.3 AstraZeneca plc Autoimmune Disease Drug Introduction
11.6.4 AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2016-2021)
11.6.5 AstraZeneca plc Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Autoimmune Disease Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Autoimmune Disease Drug Introduction
11.8.4 Roche Revenue in Autoimmune Disease Drug Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Biogen
11.9.1 Biogen Company Details
11.9.2 Biogen Business Overview
11.9.3 Biogen Autoimmune Disease Drug Introduction
11.9.4 Biogen Revenue in Autoimmune Disease Drug Business (2016-2021)
11.9.5 Biogen Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Autoimmune Disease Drug Introduction
11.10.4 Amgen Revenue in Autoimmune Disease Drug Business (2016-2021)
11.10.5 Amgen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Autoimmune Disease Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of NSAIDs
Table 3. Key Players of Anti-Inflammatory
Table 4. Key Players of Interferons
Table 5. Key Players of Antihyperglycemics
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Autoimmune Disease Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Autoimmune Disease Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Autoimmune Disease Drug Market Share by Regions (2016-2021)
Table 11. Global Autoimmune Disease Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Autoimmune Disease Drug Market Share by Regions (2022-2027)
Table 13. Autoimmune Disease Drug Market Trends
Table 14. Autoimmune Disease Drug Market Drivers
Table 15. Autoimmune Disease Drug Market Challenges
Table 16. Autoimmune Disease Drug Market Restraints
Table 17. Global Autoimmune Disease Drug Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Autoimmune Disease Drug Market Share by Players (2016-2021)
Table 19. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Drug as of 2020)
Table 20. Ranking of Global Top Autoimmune Disease Drug Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Drug Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Disease Drug Product Solution and Service
Table 24. Date of Enter into Autoimmune Disease Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Autoimmune Disease Drug Revenue Market Share by Type (2016-2021)
Table 28. Global Autoimmune Disease Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Autoimmune Disease Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Autoimmune Disease Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Autoimmune Disease Drug Revenue Market Share by Application (2016-2021)
Table 32. Global Autoimmune Disease Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Autoimmune Disease Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Autoimmune Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Autoimmune Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Autoimmune Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Autoimmune Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Autoimmune Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Autoimmune Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Autoimmune Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Autoimmune Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Autoimmune Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Autoimmune Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Autoimmune Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Autoimmune Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Autoimmune Disease Drug Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Autoimmune Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Autoimmune Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Autoimmune Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Autoimmune Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Autoimmune Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Autoimmune Disease Drug Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Autoimmune Disease Drug Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Disease Drug Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Autoimmune Disease Drug Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Autoimmune Disease Drug Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Laboratories Company Details
Table 65. Abbott Laboratories Business Overview
Table 66. Abbott Laboratories Autoimmune Disease Drug Product
Table 67. Abbott Laboratories Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 68. Abbott Laboratories Recent Development
Table 69. Pfizer Company Details
Table 70. Pfizer Business Overview
Table 71. Pfizer Autoimmune Disease Drug Product
Table 72. Pfizer Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 73. Pfizer Recent Development
Table 74. AbbVie Company Details
Table 75. AbbVie Business Overview
Table 76. AbbVie Autoimmune Disease Drug Product
Table 77. AbbVie Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 78. AbbVie Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Autoimmune Disease Drug Product
Table 82. Eli Lilly Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Bristol-Myers Squibb Company Details
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Autoimmune Disease Drug Product
Table 87. Bristol-Myers Squibb Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 88. Bristol-Myers Squibb Recent Development
Table 89. AstraZeneca plc Company Details
Table 90. AstraZeneca plc Business Overview
Table 91. AstraZeneca plc Autoimmune Disease Drug Product
Table 92. AstraZeneca plc Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca plc Recent Development
Table 94. GlaxoSmithKline Company Details
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Autoimmune Disease Drug Product
Table 97. GlaxoSmithKline Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 98. GlaxoSmithKline Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 102. Roche Recent Development
Table 103. Biogen Company Details
Table 104. Biogen Business Overview
Table 105. Biogen Autoimmune Disease Drug Product
Table 106. Biogen Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. Amgen Company Details
Table 109. Amgen Business Overview
Table 110. Amgen Autoimmune Disease Drug Product
Table 111. Amgen Revenue in Autoimmune Disease Drug Business (2016-2021) & (US$ Million)
Table 112. Amgen Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Drug Market Share by Type: 2020 VS 2027
Figure 2. NSAIDs Features
Figure 3. Anti-Inflammatory Features
Figure 4. Interferons Features
Figure 5. Antihyperglycemics Features
Figure 6. Others Features
Figure 7. Global Autoimmune Disease Drug Market Share by Application: 2020 VS 2027
Figure 8. Rheumatoid Arthritis Case Studies
Figure 9. Type 1 Diabetes Case Studies
Figure 10. Multiple Sclerosis Case Studies
Figure 11. Psoriasis Case Studies
Figure 12. Lupus Case Studies
Figure 13. Inflammatory Bowel Disease Case Studies
Figure 14. Others Case Studies
Figure 15. Autoimmune Disease Drug Report Years Considered
Figure 16. Global Autoimmune Disease Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Autoimmune Disease Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Autoimmune Disease Drug Market Share by Regions: 2020 VS 2027
Figure 19. Global Autoimmune Disease Drug Market Share by Regions (2022-2027)
Figure 20. Global Autoimmune Disease Drug Market Share by Players in 2020
Figure 21. Global Top Autoimmune Disease Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Drug as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Autoimmune Disease Drug Revenue in 2020
Figure 23. Global Autoimmune Disease Drug Revenue Market Share by Type (2016-2021)
Figure 24. Global Autoimmune Disease Drug Revenue Market Share by Type (2022-2027)
Figure 25. North America Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Autoimmune Disease Drug Market Share by Type (2016-2027)
Figure 27. North America Autoimmune Disease Drug Market Share by Application (2016-2027)
Figure 28. North America Autoimmune Disease Drug Market Share by Country (2016-2027)
Figure 29. United States Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Autoimmune Disease Drug Market Share by Type (2016-2027)
Figure 33. Europe Autoimmune Disease Drug Market Share by Application (2016-2027)
Figure 34. Europe Autoimmune Disease Drug Market Share by Country (2016-2027)
Figure 35. Germany Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Autoimmune Disease Drug Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Autoimmune Disease Drug Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Autoimmune Disease Drug Market Share by Region (2016-2027)
Figure 45. China Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Autoimmune Disease Drug Market Share by Type (2016-2027)
Figure 53. Latin America Autoimmune Disease Drug Market Share by Application (2016-2027)
Figure 54. Latin America Autoimmune Disease Drug Market Share by Country (2016-2027)
Figure 55. Mexico Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Autoimmune Disease Drug Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Autoimmune Disease Drug Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Autoimmune Disease Drug Market Share by Country (2016-2027)
Figure 61. Turkey Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Autoimmune Disease Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 67. Eli Lilly Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 69. AstraZeneca plc Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 70. GlaxoSmithKline Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 71. Roche Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 72. Biogen Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 73. Amgen Revenue Growth Rate in Autoimmune Disease Drug Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed

Global Meniere Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-4490 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、メニエール病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（めまい、耳分泌物、その他）、用途別市場規模（病院・クリニック、専門センター）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界のバッテン病治療薬パイプライン市場規模・現状・予測（2021年-2027年）

Global Batten Disease Drug Pipeline Market Size, Status and Forecast 2021-2027
QFJ1-3890 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、バッテン病治療薬パイプラインの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子治療薬、造血幹細胞治療薬）、用途別市場規模（病院＆診療所、専門施設）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の鎌状赤血球症治療薬に伴う血管閉塞危機市場規模・現状・予測（2021年-2027年）

Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market Size, Status and Forecast 2021-2027
QFJ1-6062 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、鎌状赤血球症治療薬に伴う血管閉塞危機の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SGD-2083、クリザンリズマブ、PF-04447943、NVX-508、その他）、用途別市場規模（クリニック、病...

世界の自己免疫疾患診断市場規模・現状・予測（2021年-2027年）

Global Diagnosis of Autoimmune Diseases Market Size, Status and Forecast 2021-2027
QFJ1-4125 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、自己免疫疾患診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（日常臨床検査、炎症マーカー、自己抗体＆免疫学検査、その他検査）、用途別市場規模（関節リウマチ、全身性エリテマトーデス、シェーグレン症候群...

世界の自己免疫性肝炎治療市場規模・現状・予測（2021年-2027年）

Global Autoimmune Hepatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3872 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、自己免疫性肝炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤、注射剤、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イ...

世界の自己免疫性溶血性貧血治療薬市場規模・現状・予測（2021年-2027年）

Global Autoimmune Hemolytic Anemia Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-3871 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、自己免疫性溶血性貧血治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コルチコステロイド、モノクローナル抗体、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北...

世界のフォン・ヴィレブランド病治療市場規模・現状・予測（2021年-2027年）

Global Von Willebrand Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5033 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、フォン・ヴィレブランド病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Veyvondi、Humate-P、Alphanate、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模...

世界のペイロニー病治療市場規模・現状・予測（2021年-2027年）

Global Peyronie’s Disease Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4696 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、ペイロニー病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、手術）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界の関節疾患治療薬市場規模・現状・予測（2021年-2027年）

Global Joint Disease Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4400 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、関節疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物療法、リハビリテーション、外科手術）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
世界の炎症性腸疾患体外診断市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indicatio…
炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…